Alkyltransferase-like protein clusters scan DNA rapidly over long distances and recruit NER to alkyl-DNA lesions
Alkyltransferase-like protein clusters scan DNA rapidly over long distances and recruit NER to alkyl-DNA lesions
复制标题
DOI:
10.1073/pnas.1916860117
复制
发表时间:
2020-04
期刊:
影响因子:
--
通讯作者:
Natascha Rill;Ann Mukhortava;S. Lorenz;I. Tessmer
中科院分区:
文献类型:
--
作者:
Natascha Rill;Ann Mukhortava;S. Lorenz;I. Tessmer
Significance We directly visualize cotranslocation on DNA by the alkyltransferase-like protein, ATL, and UvrA, the initiating enzyme of prokaryotic nucleotide excision repair (NER). Our findings offer an enhanced understanding of the recruitment of NER to nonnative NER target lesions. Furthermore, we elucidate the mechanism of DNA lesion search and recognition by ATL and its catalytically active homolog AGT. Our data support a paradigm for the transition from oligomeric lesion search complexes of ATL (and AGT) to the repair-initiating, monomeric protein complexes based on the dissociation of oligomeric structures due to stable, stronger DNA bending at a target lesion. Alkylation of guanine bases in DNA is detrimental to cells due to its high mutagenic and cytotoxic potential and is repaired by the alkyltransferase AGT. Additionally, alkyltransferase-like proteins (ATLs), which are structurally similar to AGTs, have been identified in many organisms. While ATLs are per se catalytically inactive, strong evidence has suggested that ATLs target alkyl lesions to the nucleotide excision repair system (NER). Using a combination of single-molecule and ensemble approaches, we show here recruitment of UvrA, the initiating enzyme of prokaryotic NER, to an alkyl lesion by ATL. We further characterize lesion recognition by ATL and directly visualize DNA lesion search by highly motile ATL and ATL–UvrA complexes on DNA at the molecular level. Based on the high similarity of ATLs and the DNA-interacting domain of AGTs, our results provide important insight in the lesion search mechanism, not only by ATL but also by AGT, thus opening opportunities for controlling the action of AGT for therapeutic benefit during chemotherapy.